These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 33925558)
1. The Real Need for Regenerative Medicine in the Future of Congenital Heart Disease Treatment. Matsuzaki Y; Wiet MG; Boe BA; Shinoka T Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33925558 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular tissue engineering: From basic science to clinical application. Fioretta ES; von Boehmer L; Motta SE; Lintas V; Hoerstrup SP; Emmert MY Exp Gerontol; 2019 Mar; 117():1-12. PubMed ID: 29604404 [TBL] [Abstract][Full Text] [Related]
3. Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine. Hinderer S; Brauchle E; Schenke-Layland K Adv Healthc Mater; 2015 Nov; 4(16):2326-41. PubMed ID: 25778713 [TBL] [Abstract][Full Text] [Related]
4. Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions. Motta SE; Lintas V; Fioretta ES; Hoerstrup SP; Emmert MY Expert Rev Med Devices; 2018 Jan; 15(1):35-45. PubMed ID: 29257706 [TBL] [Abstract][Full Text] [Related]
6. Meeting the need for regenerative therapies: translation-focused analysis of U.S. regenerative medicine opportunities in cardiovascular and peripheral vascular medicine using detailed incidence data. Tillman B; Hardin-Young J; Shannon W; Russell AJ; Parenteau NL Tissue Eng Part B Rev; 2013 Apr; 19(2):99-115. PubMed ID: 23031078 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Tissue Engineering and Regeneration: A Plead for Further Knowledge Convergence. Bouten CVC; Cheng C; Vermue IM; Gawlitta D; Passier R Tissue Eng Part A; 2022 Jun; 28(11-12):525-541. PubMed ID: 35382591 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular tissue engineering: where we come from and where are we now? Smit FE; Dohmen PM Med Sci Monit Basic Res; 2015 Jan; 21():1-3. PubMed ID: 25623227 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory and regenerative processes in bioresorbable synthetic pulmonary valves up to two years in sheep-Spatiotemporal insights augmented by Raman microspectroscopy. De Kort BJ; Marzi J; Brauchle EM; Lichauco AM; Bauer HS; Serrero A; Dekker S; Cox MAJ; Schoen FJ; Schenke-Layland K; Bouten CVC; Smits AIPM Acta Biomater; 2021 Nov; 135():243-259. PubMed ID: 34509697 [TBL] [Abstract][Full Text] [Related]
15. Creation of viable pulmonary artery autografts through tissue engineering. Shinoka T; Shum-Tim D; Ma PX; Tanel RE; Isogai N; Langer R; Vacanti JP; Mayer JE J Thorac Cardiovasc Surg; 1998 Mar; 115(3):536-45; discussion 545-6. PubMed ID: 9535439 [TBL] [Abstract][Full Text] [Related]
16. Porcine Umbilical Cord Perivascular Cells for Preclinical Testing of Tissue-Engineered Heart Valves. Latifi N; Lecce M; Simmons CA Tissue Eng Part C Methods; 2021 Jan; 27(1):35-46. PubMed ID: 33349127 [TBL] [Abstract][Full Text] [Related]
17. Current status and future trends of reconstructing a vascularized tissue-engineered trachea. Shen Z; Xia T; Zhao J; Pan S Connect Tissue Res; 2023 Sep; 64(5):428-444. PubMed ID: 37171223 [TBL] [Abstract][Full Text] [Related]
18. Current Status of Tissue Engineering Heart Valve. Shinoka T; Miyachi H World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):677-684. PubMed ID: 27834758 [TBL] [Abstract][Full Text] [Related]
19. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. Shin'oka T; Matsumura G; Hibino N; Naito Y; Watanabe M; Konuma T; Sakamoto T; Nagatsu M; Kurosawa H J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1330-8. PubMed ID: 15942574 [TBL] [Abstract][Full Text] [Related]